Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation

Hypertension

Volumn 55, Issue 4, 2010, Pages 905-910

  Chrissobolis, Sophocles ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cerebral arteries; Genetically altered mice; Mitochondria; Oxidative stress

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; TEMPOL; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BASILAR ARTERY; BRAIN CIRCULATION; BRAIN PROTECTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME DEFICIENCY; ENZYME LOCALIZATION; FEMALE; GENETIC MODEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SEXUAL DEVELOPMENT; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BASILAR ARTERY; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; MALE; MICE; MICE, KNOCKOUT; NITROPRUSSIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEX CHARACTERISTICS; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 77950505335     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.147041     Document Type: Article

References (32)

1. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7:476-484.
2. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med. 2008;14:495-502.
3. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension. 2003;41:50-55.
4. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol. 2003;284:R893-R912.
5. Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antiox Redox Signalling. 2005;7:1302-1314.
6. 1 receptors in cerebral vascular dysfunction with aging. Am J Physiol Heart Circ Physiol. 2009;296:H1914-H1919.
7. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008;451:904-913.
8. Chrissobolis S, Didion SP, Kinzenbaw DA, Schrader LI, Dayal S, Lentz SR, Faraci FM. Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension. 2008; 51:872-877.
9. Didion SP, Faraci FM. Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke. 2003; 34:2038-2042.
10. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab. 2006;26:449-455.
11. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcircu-lation through Nox-2-derived radicals. Arterioscler Thromb Vasc Biol. 2006;26:826-832.
12. Miller AA, Drummond GR, Schmidt HHW, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005;97:1055-1062.
13. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: Comparison of angiotensin II and diazoxide. Hypertension. 2005;45:438-444.
14. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of an-giotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008; 102:488-496.
15. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens. 2008;26:2176-2184.
16. Oldendorf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol. 1977;1:409-417.
17. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004;24: 1367-1373.
18. Andresen JJ, Faraci FM, Heistad DD. Vascular responses in Mn-SOD deficient mice. Am J Physiol Heart Circ Physiol. 2004;287: H1141-H1148.
19. Capone C, Anrather J, Milner TA, Iadecola C. Estrous cycle dependent neurovascular dysfunction induced by angiotensin II in the mouse neo-cortex. Hypertension. 2009;54:302-307.
20. Girouard H, Lessard A, Capone C, Milner TA, Iadecola C. The neuro-vascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic. Am J Physiol Heart Circ Physiol. 2007;294: H156-H163.
21. Faraci FM, Modrick ML, Lynch CM, Didion LA, Fegan PE, Didion SP. Selective cerebral vascular dysfunction in Mn-SOD-deficient mice. J Appl Physiol. 2006;100:2089-2093.
22. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension. 2009;54:619-624.
23. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol. 2002;13:2860-2868.
24. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res. 1990;66:8-17.
25. Miller AA, Drummond GR, Mast AE, Schmidt HH, Sobey CG. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke. 2007;38:2142-2149.
26. Didion SP, Kinzenbaw DA, Faraci FM. Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction. Hypertension. 2005;46:1147-1153.
27. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004;95:1019-1026.
28. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology. 2006;21:269-280.
29. Brown KA, Didion SP, Andresen JJ, Faraci FM. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler Thromb Vasc Biol. 2007;27: 1941-1946.
30. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, Abe Y. Role of NAD(P)H oxidase-and mitochondria-derived reactive oxygen species in cardioprotection of is-chemic reperfusion injury by angiotensin II. Hypertension. 2005;45: 860-866.
31. Block K, Gorin Y, Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci USA. 2009;106:14385-14390.
32. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308:1583-1587.